Iovance Biotherapeutics, Inc. logo

Iovance Biotherapeutics, Inc. Employee Directory

Biotechnology ResearchCalifornia, United States501-1000 Employees

Iovance Biotherapeutics, Inc. is a biotechnology company focused on developing tumor infiltrating lymphocyte (TIL) therapies for cancer patients. It aims to harness the immune system to recognize and destroy cancer cells in each individual, pursuing a per-patient treatment strategy. The TIL platform has produced clinical data suggesting activity across several solid tumor types, and the company continues to advance cell-therapy innovations, including gene-edited approaches. The firm is headquartered in the San Francisco Bay Area and operates the Iovance Cell Therapy Center manufacturing facility in Philadelphia, with a research site in Tampa, Florida. As it expands its commercial launch and research efforts, it is building internal manufacturing capabilities to support scale and execution. In 2025, the company appointed Corleen Roche as Chief Financial Officer, with the appointment effective in August 2025.

Find Iovance Biotherapeutics, Inc. employees' phone numbers or email addresses

Iovance Biotherapeutics, Inc. Global Highlights

Location
Employees

North America
978

Minus sign iconPlus sign icon
  • United States Of America
    974
  • Canada
    4

Europe
15

Minus sign iconPlus sign icon
  • United Kingdom Of Great Britain And Northern Ireland
    9
  • Netherlands
    4
  • Switzerland
    2

Asia
3

Minus sign iconPlus sign icon
  • India
    2
  • Iran
    1

Iovance Biotherapeutics, Inc.'s Leadership

  • Chief Financial Officer at Iovance Biotherapeutics, Inc.
    B. B.
    Chief Financial Officer
  • Vp Of Finance, Corporate Controller at Iovance Biotherapeutics, Inc.
    J. H.
    Vp Of Finance, Corporate Controller
  • Vice President Of Finance, Corporate Controller at Iovance Biotherapeutics, Inc.
    C. S.
    Vice President Of Finance, Corporate Controller
  • Executive Assistant To Chief Medical Officer at Iovance Biotherapeutics, Inc.
    C. A.
    Executive Assistant To Chief Medical Officer
  • Owner at Iovance Biotherapeutics, Inc.
    N. H.
    Owner
  • Executive Vice President, Quality at Iovance Biotherapeutics, Inc.
    K. S.
    Executive Vice President, Quality
  • Global Executive Medical Director (ex-Us) Til Therapy (immuno-Oncology) at Iovance Biotherapeutics, Inc.
    M. B.
    Global Executive Medical Director (ex-Us) Til Therapy (immuno-Oncology)
  • Human Resources Director at Iovance Biotherapeutics, Inc.
    E. G.
    Human Resources Director

Iovance Biotherapeutics, Inc. Employee Metrics

100%
50%
0%
2026
2025
  • Manufacturing
  • Operations
  • Quality Assurance
  • Engineering
  • Analytics
  • Other
  • Legal
  • Administrative
  • Biotechnology
  • Supply Chain

Contact profiles from Iovance Biotherapeutics, Inc.

Name
Title
Contact
Location
Last Update
  • Associate Director, Regulatory Affairs Cmc at Iovance Biotherapeutics, Inc.
    R. D.
    Associate Director, Regulatory Affairs Cmc
    Oct 22, 2024
  • Director, Quality Engineering at Iovance Biotherapeutics, Inc.
    S. B.
    Director, Quality Engineering
    Oct 21, 2024
  • Associate Director Facilities Engineering at Iovance Biotherapeutics, Inc.
    T. K.
    Associate Director Facilities Engineering
    Oct 23, 2024
  • Manager Analytical Development at Iovance Biotherapeutics, Inc.
    J. H.
    Manager Analytical Development
    Sep 02, 2026
  • Global Product Quality Leader at Iovance Biotherapeutics, Inc.
    K. S.
    Global Product Quality Leader
    Sep 04, 2026
  • Global Product Quality Lead at Iovance Biotherapeutics, Inc.
    M. B.
    Global Product Quality Lead
    Apr 02, 2026
  • Senior Clinical Trial Manager at Iovance Biotherapeutics, Inc.
    H. A.
    Senior Clinical Trial Manager
    Feb 06, 2026
  • Manager, Clinical Data Management at Iovance Biotherapeutics, Inc.
    R. R.
    Manager, Clinical Data Management
    Aug 25, 2026
  • Senior Drug Safety Manager at Iovance Biotherapeutics, Inc.
    E. K.
    Senior Drug Safety Manager
    Bay
    Apr 13, 2026
  • Quality Assurance Manager at Iovance Biotherapeutics, Inc.
    M. K.
    Quality Assurance Manager
    Sep 04, 2026

Frequently Asked Questions

What is Iovance Biotherapeutics, Inc. known for?

Minus sign iconPlus sign icon
Iovance Biotherapeutics, Inc. was founded in 2007 and operates in the Biotechnology Research industry. You can contact Iovance Biotherapeutics, Inc.'s main corporate office by phone at . Explore Iovance Biotherapeutics, Inc.'s company overview page for more information.

What is Iovance Biotherapeutics, Inc.'s most common email format?

Minus sign iconPlus sign icon
Iovance Biotherapeutics, Inc. employees' email format typically follows the pattern of First.Last@iovance.com. Trying to find reliable and up-to-date employee contact data? Find more Iovance Biotherapeutics, Inc. email formats with LeadIQ.

How many employees does Iovance Biotherapeutics, Inc. have currently?

Minus sign iconPlus sign icon
Iovance Biotherapeutics, Inc. has approximately 931 employees as of August 2026. These team members are located across 3 continents, including North America, Europe and Asia.

Who are Iovance Biotherapeutics, Inc.'s key employees and leadership?

Minus sign iconPlus sign icon

As of August 2026, Iovance Biotherapeutics, Inc.'s key employees include:

  • Chief Financial Officer: B. B.
  • Vp Of Finance, Corporate Controller: J. H.
  • Vice President Of Finance, Corporate Controller: C. S.
  • Executive Assistant To Chief Medical Officer: C. A.
  • Owner: N. H.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.